You are here: Industry Insights > cancer

News List

Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ PR Newswire
July 29, 2025
Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate JSKN003 has been granted Orphan Drug Designation by the FDA for the treatment of gastric cancer?and gastroesophageal junction cancer (GC/GEJ).
AXA and Prosper Health introduce pioneering dedicated cancer case management service in Greater Bay Area[1] PharmaSources
January 22, 2025
AXA Hong Kong and Macau partners with Prosper Health to launch the Greater Bay Area Cancer Medical Concierge Service Network for eligible customers, integrating resources to meet cross - border medical demands.
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy PharmaSources
January 14, 2025
German research institute BioMed X started a new partnership with Daiichi Sankyo, a Japanese pharmaceutical company, to advance the development of bi- and multi-specific biologics for treating solid tumors
Olympus Launches New 4K Camera Head for Urological Endoscopy PharmaSources
September 24, 2024
Unified Visualization with True 4K Imaging and 4K Narrow Band Imaging as well as blue light observation
10 Studies on InnoCare’s Oncology Pipelines Selected at the Upcoming 65th Annual Meeting of ASH PharmaSources
November 15, 2023
InnoCare Pharma,announced today that 10 studies from InnoCare's oncology pipeline were selected for presentation at the 65th American Society of Hematology (ASH) Annual Meeting on December 9-12, 2023 in San Diego, California, United States.
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients PharmaSources
May 05, 2023
April 12, 2023，ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for IOS-1002.
FDA Raises Concerns About China-Developed Drugs FirstWordPharma
February 10, 2022
A negative FDA staff report for Eli Lilly and partner Innovent Biologics' anti-PD-1 cancer drug sintilimab could slow the plans of large Western drugmakers such as Novartis looking to sell Chinese-tested medicines...
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN AmericanPharmaceuticalReview
February 09, 2022
Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.
Rural Residents More Fatalistic About Cancer drugs.com
February 09, 2022
Rural residents show higher levels of cancer fatalism and cancer information overload than urban residents, according to a study published ...
cancer patients miss out on innovative new treatments pharmatimes
February 07, 2022
Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes.